Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.
2.

[The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].

Ibsen H, Pedersen OL, Dahlöf B, Kjeldsen SE, Lindholm LH.

Ugeskr Laeger. 2003 Jan 27;165(5):456-9. Danish.

PMID:
12599843
[PubMed - indexed for MEDLINE]
3.

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB.

J Am Coll Cardiol. 2005 Mar 1;45(5):712-9.

PMID:
15734615
[PubMed - indexed for MEDLINE]
Free Article
4.

Losartan: in the reduction of stroke risk in patients with hypertension and left ventricular hypertrophy.

Waugh J, Keating GM.

Am J Cardiovasc Drugs. 2003;3(5):371-7; discussion 378-9. Review.

PMID:
14728071
[PubMed - indexed for MEDLINE]
6.

Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.

Devereux RB, Dahlöf B, Kjeldsen SE, Julius S, Aurup P, Beevers G, Edelman JM, de Faire U, Fyhrquist F, Helle Berg S, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn S, Wedel H; LIFE Study Group.

Ann Intern Med. 2003 Aug 5;139(3):169-77.

PMID:
12899584
[PubMed - indexed for MEDLINE]
7.

Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study.

Os I, Franco V, Kjeldsen SE, Manhem K, Devereux RB, Gerdts E, Hille DA, Lyle PA, Okin PM, Dahlöf B, Oparil S.

Hypertension. 2008 Apr;51(4):1103-8. doi: 10.1161/HYPERTENSIONAHA.107.105296. Epub 2008 Feb 7.

PMID:
18259029
[PubMed - indexed for MEDLINE]
Free Article
8.

The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.

Kjeldsen SE, Lyle PA, Kizer JR, Dahlöf B, Devereux RB, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn SM, Harris KE, Wedel H; LIFE Study Group.

J Clin Hypertens (Greenwich). 2005 Mar;7(3):152-8.

PMID:
15785156
[PubMed - indexed for MEDLINE]
9.

The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study.

Fossum E, Gleim GW, Kjeldsen SE, Kizer JR, Julius S, Devereux RB, Brady WE, Hille DA, Lyle PA, Dahlöf B.

J Intern Med. 2007 Oct;262(4):439-48.

PMID:
17875180
[PubMed - indexed for MEDLINE]
10.

Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy.

Franklin SS, Wachtell K, Papademetriou V, Olsen MH, Devereux RB, Fyhrquist F, Ibsen H, Kjeldsen SE, Dahlöf B.

Hypertension. 2005 Sep;46(3):492-9. Epub 2005 Aug 22.

PMID:
16116047
[PubMed - indexed for MEDLINE]
Free Article
11.

Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.

Fyhrquist F, Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Hille DA, Lyle PA, Edelman JM, Snapinn SM, Wedel H; LIFE Study Group.

Hypertension. 2005 Apr;45(4):580-5.

PMID:
15790960
[PubMed - indexed for MEDLINE]
Free Article
12.

In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.

Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Lindholm LH, Dahlöf B; LIFE Study Investigators.

Hypertension. 2007 Nov;50(5):984-90. Epub 2007 Sep 24.

PMID:
17893425
[PubMed - indexed for MEDLINE]
Free Article
13.

[Treatment of hypertension in patients with left ventricular hypertrophy].

Omvik P, Bratland B, Gerhardsen G, Gisholt K, Risanger T, Smedsrud T, Kjeldsen SE.

Tidsskr Nor Laegeforen. 2004 Mar 18;124(6):788-91. Norwegian.

PMID:
15039810
[PubMed - indexed for MEDLINE]
Free Article
14.

Losartan: a review of its use in stroke risk reduction in patients with hypertension and left ventricular hypertrophy.

Moen MD, Wagstaff AJ.

Drugs. 2005;65(18):2657-74. Review.

PMID:
16392883
[PubMed - indexed for MEDLINE]
15.

Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.

Ibsen H, Wachtell K, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y; LIFE substudy.

J Hypertens. 2004 Sep;22(9):1805-11.

PMID:
15311110
[PubMed - indexed for MEDLINE]
16.

Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.

Okin PM, Wachtell K, Kjeldsen SE, Julius S, Lindholm LH, Dahlöf B, Hille DA, Nieminen MS, Edelman JM, Devereux RB.

Circ Arrhythm Electrophysiol. 2008 Dec;1(5):337-43. doi: 10.1161/CIRCEP.108.795351. Epub 2008 Dec 2.

PMID:
19808428
[PubMed - indexed for MEDLINE]
Free Article
17.

Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.

Kizer JR, Dahlöf B, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Wachtell K, Edelman JM, Snapinn SM, Harris KE, Devereux RB.

Hypertension. 2005 Jan;45(1):46-52. Epub 2004 Dec 6.

PMID:
15583076
[PubMed - indexed for MEDLINE]
Free Article
18.

Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.

Jönsson B, Carides GW, Burke TA, Dasbach EJ, Lindholm LH, Dahlöf B; LIFE Study Group.

J Hypertens. 2005 Jul;23(7):1425-31.

PMID:
15942467
[PubMed - indexed for MEDLINE]
19.

Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.

Devereux RB, Dahlöf B.

Curr Med Res Opin. 2007 Feb;23(2):443-57. Review.

PMID:
17288698
[PubMed - indexed for MEDLINE]
20.

Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study.

Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Snapinn SM, Wan Y, Lyle PA.

Diabetes Care. 2006 Mar;29(3):595-600.

PMID:
16505512
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk